Peer Review History
| Original SubmissionSeptember 26, 2019 |
|---|
|
PONE-D-19-27108 Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal Collection PLOS ONE Dear Dr. Spekker, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As suggested by the reviewers, please focus on re-structuring the manuscript by removing redundant information and checking thoroughly for English language. Address all the reviewer comments on the manuscript in addition to the rebuttal letter. We would appreciate receiving your revised manuscript by Feb 24 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Selvakumar Subbian, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. In your manuscript, please provide additional information regarding the specimens used in your study. Ensure that you have reported specimen numbers and complete repository information, including museum name and geographic location. If permits were required, please ensure that you have provided details for all permits that were obtained, including the full name of the issuing authority, and add the following statement: 'All necessary permits were obtained for the described study, which complied with all relevant regulations.' If no permits were required, please include the following statement: 'No permits were required for the described study, which complied with all relevant regulations.' For more information on PLOS ONE's requirements for paleontology and archaeology research, see " ext-link-type="uri" xlink:type="simple">https://journals.plos.org/plosone/s/submission-guidelines#loc-paleontology-and-archaeology-research." [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Nicely written though extensive manuscript. All the sections are clear and focus on significant points of discussion. It seems repetitions of the text. Authors can significantly reduce words count by deleting the repetitions. Reviewer #2: This is an interesting study of skeletal changes related to tuberculosis, using a well-characterized collection. The authors identify that a particular finding- granular impressions in the skull- was present in 29% of skeletons where TB was the cause of death, compared with 3% without TB disease. There are numerous strengths to this study, particularly the blinding of study personnel in reviewing these skulls, and the detailed methodology provided. The results are surprising, but support the authors' contention that CNS TB disease is more common than reported in clinical studies of TB presentation. Major comments: -I would take issue with the association of these GIs with a diagnosis of "TBM", more accurate would be to refer to these findings as evidence of CNS TB. The formation of CNS tuberculomas precedes, in all instances, with the pathophysiologic events of TBM- namely, tuberculoma rupture and inflammatory response in the meninges. While some of these patients may have had referable signs/symptoms of TBM, many may have had clinically silent CNS tuberculomas. That is an important distinction, as we do not routinely perform the types of diagnostic studies that would detect these lesions among pulmonary TB patients. The absence of TBM relapses post pulmonary TB treatment suggests that these lesions are adequately treated with the standard TB drug regimen. I recommend making the distinction throughout the manuscript that you are identifying/evaluating a marker of CNS TB. -If possible, it would be interesting to examine for the types of changes that would characterize the transition from CNS TB to TBM, including some of the features associated with CNS vascular disease that are described. The subset of CNS TB patients who have developed TBM could be identified with these additional features, perhaps that is a separate study, but this concept is presented briefly in the manuscript and could be developed in greater detail, or at least clarified. -The discussion should include a single paragraph that summarizes all the limitations, which are scattered a bit. A chief limitation would be the absence of children, as we know that CNS TB is more common among young children. It would be very useful to validate these findings in this age cohort, where we would expect the proportion of skulls with GIs to be even greater than observed here among adults. Minor comments -Line 73- often, there are no identifiable risk factors for the re-activation of TB disease from latency, this process remains poorly understood. Line 80- all patients with latent TB are at risk for progressing to active TB, but 5-15% of patients (without LTBI treatment) do progress. -Line 85-90- not sure of the relevance of this discussion of drug resistant TB, given the focus on the pre-antibiotic era. -Line 138- is this true? wouldn't the CNS tuberculomas, slowly enlarging over time, be the incipient factor, the cause rather than the effect of TBM. -Line 216- would emphasize here that the skeletal reviewer was "blinded" as to the cause of death. -The discussion is quite length, includes much information tangential to the project (e.g. Line 340 onwards), or re-states findings from the results (Line 397 onwards). The manuscript would be improved with substantial editing of these sections. -In my view, the take home message gets lost and should be more emphasized- CNS TB disease, as detected by the GIs in skull from the pre-antibiotic era, is more common than previously recognized. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Christopher Vinnard [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal Collection PONE-D-19-27108R1 Dear Dr. Spekker, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Selvakumar Subbian, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-27108R1 Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal Collection Dear Dr. Spekker: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Selvakumar Subbian Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .